AGP Executive Report
Last update: 3 hours agoEbola Emergency: The DRC reports 9,066 confirmed cases and 4,381 deaths across seven provinces. Containment is faltering, and the Bundibugyo strain has no approved vaccine or treatment. Uganda has secured 3,000 trial doses as a vaccine trial approaches. Vaccine Ethics: Guinea-Bissau says it has not approved a proposed hepatitis B vaccine trial in newborns, stressing that research involving children requires ethical review. US health officials also say the study has not been authorised. Health Financing: Nigeria plans to inject an additional $3bn into its health sector by 2030, while Sierra Leone lawmakers and UNECA are pursuing more sustainable funding. Local Medicines: Emzor’s founder is urging government support for Nigerian drug makers as African health leaders push to expand local medicine and vaccine production. Prevention and Care: WHO warns immunisation gaps leave Nigerian children vulnerable. HIV prevention services in Uganda and Zimbabwe also fell sharply after US aid cuts, according to a recent analysis. Nigeria is set to host a global antimicrobial-resistance conference in December.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
